Ford, Kyle

Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme

Triplett, T. A., Garrison, K. C., Marshall, N., Donkor, M., Blazeck, J., Lamb, C., Qerqez, A., Dekker, J. D., Tanno, Y., Lu, W.-C., et al. (2018) · Nature Biotechnology

Cancer Immunotherapy and BiomarkersTryptophan and brain disorders

Cited by 321

Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange

Kelton, W., Waindok, A. C., Pesch, T., Pogson, M., Ford, K., Parola, C., & Reddy, S. T. (2017) · Scientific Reports

CRISPR and Genetic EngineeringCAR-T cell therapy research

Cited by 21